1998
DOI: 10.1016/s0006-8993(97)01448-0
|View full text |Cite
|
Sign up to set email alerts
|

The effect of MK-801 and of brain-derived polypeptides on the development of ischemic lesion induced by photothrombotic occlusion of the distal middle cerebral artery in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

1998
1998
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 41 publications
1
10
0
Order By: Relevance
“…The balance of positive and negative sequelae of SD depended on the model, number of waves, and extent of general hypoxia, and the fundamentally changing properties of the SD itself. Morphological verification which we reported in [27] showed that the volume of cortical damage around the ischemic focus increased almost two-fold on administration of MK-801 as compared with the control group (22 • 3 and 13 • 2 mm 2 respectively). In the intact brain with a good blood supply, SD provokes intense episodes of vasodilation [28,34,41] and increases the efficiency of brain oxygen uptake and the rate of metabolic processes in nervous tissue [14,15,25,32,34].…”
Section: Discussionsupporting
confidence: 70%
See 2 more Smart Citations
“…The balance of positive and negative sequelae of SD depended on the model, number of waves, and extent of general hypoxia, and the fundamentally changing properties of the SD itself. Morphological verification which we reported in [27] showed that the volume of cortical damage around the ischemic focus increased almost two-fold on administration of MK-801 as compared with the control group (22 • 3 and 13 • 2 mm 2 respectively). In the intact brain with a good blood supply, SD provokes intense episodes of vasodilation [28,34,41] and increases the efficiency of brain oxygen uptake and the rate of metabolic processes in nervous tissue [14,15,25,32,34].…”
Section: Discussionsupporting
confidence: 70%
“…The neurotropic action of Cerebrolysine has now been studied in clinical conditions and by experimental physiologists [13,27,39,40]. This preparation is a mixture of free amino acids (85%) and peptides (15%).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Surprisingly, SD initiation and propagation do not require the generation or conduction of action potentials or chemical synaptic transmission (Balestrino, 1995;Largo et al, 1997;Basarsky et al, 1998), so SD is difficult to block pharmacologically. NMDA receptor antagonists can block SD in vivo (Hernandez-Caceres et al, 1987;Marrannes et al, 1988;Lauritzen and Hansen, 1992;Nellgard and Wieloch, 1992;Koroleva et al, 1998) and in brain slices (Somjen, 2001;Footitt and Newberry, 1998;Anderson and Andrew, 2002). Therefore some glutamate release is required to support SD propagation, but such release is not required for SD initiation (Obrenovitch et al, 1996).…”
Section: Introductionmentioning
confidence: 99%
“…Due to the potentially positive and negative effects of injury depolarizations on the one hand and on the other, it is also a controversial issue whether direct inhibition of injury depolarizations, for example, using N-methyl-D-aspartate receptor (NMDAR) antagonists (Hertle et al 2012; Lauritzen and Hansen 1992;Marrannes et al 1988;Sakowitz et al 2009), would have a net beneficial effect (Reinhart and Shuttleworth 2018). This discussion is further complicated by the fact that NMDAR antagonists increasingly lose efficacy against injury depolarizations where they are increasingly harmful (Hernandez-Caceres et al 1987;Koroleva et al 1998;Lauritzen and Hansen 1992;Madry et al 2010;Muller and Somjen 1998). Thus, only a bathing medium containing high concentrations of, e.g., DNQX/NBQX to block all AMPA/kainate receptors, the combination of MK-801 and APV to potently block NMDARs, and bicuculline methiodide to block GABA A receptors succeeded in preventing the signature of injury depolarization on the single neuron level in severely ischemic (Allen et al 2004;Madry et al 2010) or anoxic brain slices (Revah et al 2016).…”
Section: Inhibiting Neuronal Mass Injury As a Target Of Neuroprotectimentioning
confidence: 99%